| Revenue Disaggregation |
| Note 9. |
Revenue Disaggregation |
The Company generates product revenues from products
which are sold into the human and animal healthcare markets.
The following table presents the Company’s disaggregated revenues
by source:
| Schedule of disaggregated revenues by revenue source |
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
Three Months Ended September 30, |
|
|
Six Months Ended September 30, |
|
| |
|
2025 |
|
|
2024 |
|
|
2025 |
|
|
2024 |
|
| Human Care |
|
$ |
5,116,000 |
|
|
$ |
3,177,000 |
|
|
$ |
8,671,000 |
|
|
$ |
6,169,000 |
|
| Animal Care |
|
|
488,000 |
|
|
|
402,000 |
|
|
|
948,000 |
|
|
|
801,000 |
|
| |
|
$ |
5,604,000 |
|
|
$ |
3,579,000 |
|
|
$ |
9,619,000 |
|
|
$ |
6,970,000 |
|
The following table shows the Company’s revenues by geographic region:
| Schedule of revenues by geographic region |
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
Three Months Ended September 30, |
|
|
Six Months Ended September 30, |
|
| |
|
2025 |
|
|
2024 |
|
|
2025 |
|
|
2024 |
|
| United States |
|
$ |
1,449,000 |
|
|
$ |
675,000 |
|
|
$ |
2,454,000 |
|
|
$ |
1,317,000 |
|
| Europe |
|
|
2,151,000 |
|
|
|
1,506,000 |
|
|
|
3,619,000 |
|
|
|
2,794,000 |
|
| Asia |
|
|
1,057,000 |
|
|
|
776,000 |
|
|
|
1,719,000 |
|
|
|
1,253,000 |
|
| Latin America |
|
|
532,000 |
|
|
|
465,000 |
|
|
|
1,096,000 |
|
|
|
1,345,000 |
|
| Rest of the World |
|
|
415,000 |
|
|
|
157,000 |
|
|
|
731,000 |
|
|
|
261,000 |
|
| Total |
|
$ |
5,604,000 |
|
|
$ |
3,579,000 |
|
|
$ |
9,619,000 |
|
|
$ |
6,970,000 |
|
|